Grant / AwardRoutine 10/100
filed 2026-10-02CRBoard
CODE KENNETH REAY - Director, Chief Science Officer - $45.3K
This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy.
View source filingB
SEC EDGAR - Form 4 insider activity
Biolargo, Inc. $BLGO
Tracked equity - 2 filings indexed by Nortis
Nortis signal thesis
Recent activity is mostly routine or balanced.
0
OM buys - 90d
0
OM sells - 90d
2
Routine filings
0
Cluster filings
$74.6K
Largest trade
10/100
Avg signal score
Filing tape
Recent filings
Grant / AwardRoutine 10/100
filed 2026-10-02CPBoard
CALVERT DENNIS P - Director, President - $74.6K
This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy.
View source filing